Endocrine Toxicity | List of Frontiers open access articles

Review

Published on 30 Jan 2024

A comprehensive review on endocrine toxicity of gaseous components and particulate matter in smog

in Experimental Endocrinology

Ammara Saleem
Tanzeela Awan
Muhammad Furqan Akhtar

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1294205

8,034 views
18 citations

Review

Published on 10 Jan 2023

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes

in Diabetes: Molecular Mechanisms

Jia-Tong Ding
Kang-Ping Yang
Kong-Lan Lin
Yu-Ke Cao
Fang Zou

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1090842

10,138 views
15 citations

Case Report

Published on 28 Aug 2025

Case Report: Tislelizumab-induced delayed-onset diabetic ketoacidosis and hypothyroidism in esophageal adenocarcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhaoyang Li
Kangning Han
Li Li
Xiaochun Han
Feng Zhang
Liangqing Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1642893

1,901 views

Original Research

Published on 13 Apr 2021

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis

in Clinical Diabetes

Amy L. Zhang
Fang Wang
Lee-Shing Chang
Marie E. McDonnell
Le Min

Frontiers in Endocrinology

doi 10.3389/fendo.2021.620522

6,003 views
20 citations

Original Research

Published on 15 Apr 2024

Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research

in Cancer Endocrinology

Jun Zhao
Guangwei Liu
Xue Yang
Chuanzhou Zhang
Bing Han
Man Jiang

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1253832

3,443 views
2 citations

Original Research

Published on 31 Jan 2025

Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients

in Pharmacology of Anti-Cancer Drugs

Ting Yan
Minghui Long
Chaoyi Liu
Jiwen Zhang
Xingyu Wei
Fei Li
Dehua Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519082

5,802 views
9 citations

Systematic Review

Published on 19 Jun 2023

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Yao-Ning Feng
Guang-Yu Xie
Li Xiao
Dun-Chang Mo
Jian-Feng Huang
Peng-Hui Luo
Xiu-Juan Liang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196793

5,585 views
9 citations

Original Research

Published on 12 Mar 2020

Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study

in Genitourinary Oncology

Michael Jonathan Kucharczyk
James Man Git Tsui
Farzin Khosrow-Khavar
Boris Bahoric
Luis Souhami
Maurice Anidjar
Stephan Probst
Ahmad Chaddad
Paul Sargos
Tamim Niazi

Frontiers in Oncology

doi 10.3389/fonc.2020.00312

6,003 views
6 citations

Original Research

Published on 04 Jun 2020

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

in Skin Cancer

Chiao-En Wu
Chan-Keng Yang
Meng-Ting Peng
Pei-Wei Huang
Yu-Fen Lin
Chi-Yuan Cheng
Yao-Yu Chang
Huan-Wu Chen
Jia-Juan Hsieh
John Wen-Cheng Chang

Frontiers in Oncology

doi 10.3389/fonc.2020.00905

5,396 views
18 citations

Articles

A comprehensive review on endocrine toxicity of gaseous components and particulate matter in smog

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes

Case Report: Tislelizumab-induced delayed-onset diabetic ketoacidosis and hypothyroidism in esophageal adenocarcinoma

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis

Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research

Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis

Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan